Agilent Technologies Inc
A
View Detailed Chart
125.630USD
+2.390+1.94%
Close 09/15, 16:00（ET）Quotes delayed by 15 min
35.63BMarket Cap
29.20P/E TTM
Intraday
1m
30m
1h
D
W
M
D
Today
+1.94%
5 Days
-1.95%
1 Month
+5.39%
6 Months
+3.67%
Year to Date
-6.48%
1 Year
-8.51%
View Detailed Chart
TradingKey Stock Score
Currency: USD Updated：2025-09-15Key Insights
The company's fundamentals are relatively very healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite an average stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Score
Support & Resistance
No Data
Score Analysis
Current score
Previous score
Analyst Rating
Based on
20
analysts
Buy
Current Rating
136.767
Target Price
+10.98%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Company Highlights
StrengthsRisks
Agilent Technologies, Inc. is engaged in providing application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company’s life sciences and applied markets segment provides application-focused solutions that include instruments, consumables and software that enable customers to identify, quantify and analyze the physical and biological properties of substances and products. Its diagnostics and genomics segment includes the cell analysis, advanced manufacturing partnerships contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership, genomics and biomolecular analysis businesses. The Agilent CrossLab segment offers a service portfolio that includes repairs, parts, maintenance, installations and various other custom services to support the laboratory operations. It also offers contract development and manufacturing organization (CDMO) services.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 21.26%.
Stable Dividend
The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 21.26%.
Fairly Valued
The company’s latest PE is 30.82, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 262.65M shares, decreasing 1.37% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 33.87M shares of this stock.
News
More news coming soon, stay tuned...
Financial Indicators
EPS
No Data
Total revenue
No Data
Company
Agilent Technologies, Inc. is engaged in providing application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company’s life sciences and applied markets segment provides application-focused solutions that include instruments, consumables and software that enable customers to identify, quantify and analyze the physical and biological properties of substances and products. Its diagnostics and genomics segment includes the cell analysis, advanced manufacturing partnerships contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership, genomics and biomolecular analysis businesses. The Agilent CrossLab segment offers a service portfolio that includes repairs, parts, maintenance, installations and various other custom services to support the laboratory operations. It also offers contract development and manufacturing organization (CDMO) services.
Ticker SymbolA
CompanyAgilent Technologies Inc
CEOMr. Padraig Mcdonnell
Websitehttps://www.agilent.com/
Related Instruments
-1.04%
-3.49%
-2.77%
-0.79%
-0.06%
-1.96%
+0.39%
+1.73%
-0.11%
+1.24%
+6.10%
-1.01%
+1.36%
-2.04%
+3.75%
-0.24%
-1.13%
+0.09%
+1.23%
+1.35%
